WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
HK Stock Market Move | Lithium battery concept stocks collectively rebound, battery export tax rebate reduced, battery companies scrambling to increase battery production for exports.
HK Stock Market Move | Space industry concept stocks collectively adjusted this morning, with Goldwind Science & Technology (02208) falling more than 13% at one point.
DPC DASH (01405): High-quality and steady store expansion in Q4, driven by the "4D strategy" to promote sustainable growth flywheel.
HK Stock Market Move | Lithium battery concept stocks collectively rebound, battery export tax rebate reduced, battery companies scrambling to increase battery production for exports.
HK Stock Market Move | Space industry concept stocks collectively adjusted this morning, with Goldwind Science & Technology (02208) falling more than 13% at one point.
DPC DASH (01405): High-quality and steady store expansion in Q4, driven by the "4D strategy" to promote sustainable growth flywheel.
RECOMMEND
Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026
Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026
“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026
